Aurélie Côté-Sergent

发表

Prevalence, incidence and economic burden of schizophrenia among Medicaid beneficiaries

P. Lefebvre, D. Lin, K. Joshi, 2021, Current medical research and opinion.

Treatment Patterns and Predictors of Adherence in HIV Patients Receiving Single- or Multiple-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Patient preference and adherence.

The Concentration of Hospital-Based Medical Spending: Evidence from Canada

P. Michaud, Aurélie Côté-Sergent, Damien Échevin, 2016 .

Medication adherence, healthcare resource utilization, and costs among Medicaid beneficiaries with schizophrenia treated with once-monthly paliperidone palmitate or once-every-three-months paliperidone palmitate

P. Lefebvre, D. Lin, K. Joshi, 2021, Current medical research and opinion.

Comparing the education gradient in health deterioration among the elderly in six OECD countries.

E. Strumpf, Raquel Fonseca, Aurélie Côté-Sergent, 2020, Health policy.

Comparing the Education Gradient in Chronic Disease Incidence among the Elderly in Six OECD Countries

E. Strumpf, Raquel Fonseca, Aurélie Côté-Sergent, 2018 .

Clinical and economic burden of tumor lysis syndrome among patients with chronic lymphocytic leukemia/small lymphocytic lymphoma: A real-world US retrospective study.

K. Rogers, P. Lefebvre, Xiaoxiao Lu, 2022, Journal of managed care & specialty pharmacy.

Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy

L. Citrome, J. Sheehan, P. Lefebvre, 2021, Journal of medical economics.

End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported.

Nicolas R. Ziebarth, J. Skinner, M. Karlsson, 2017, Health affairs.

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

P. Lefebvre, N. Tandon, A. E. El Khoury, 2019, Drugs - Real World Outcomes.

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

P. Lefebvre, B. Bookhart, M. Lafeuille, 2021, Current medical research and opinion.

Treatment patterns among patients with mantle cell lymphoma and comparison of healthcare resource utilization and costs among relapsed/refractory patients treated with ibrutinib or chemoimmunotherapy: A real-world retrospective study.

N. Ghosh, P. Lefebvre, M. Lafeuille, 2021, Clinical therapeutics.

Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study

P. Lefebvre, M. Lafeuille, Aurélie Côté-Sergent, 2021, Journal of health economics and outcomes research.

An assessment of weight change associated with the initiation of a protease or integrase strand transfer inhibitor in patients with human immunodeficiency virus

P. Lefebvre, H. Hardy, M. Lafeuille, 2020, Current medical research and opinion.

Health Affairs Previously Reported End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Doorslaer

Nicolas R. Ziebarth, J. Skinner, M. Karlsson, 2017 .

Long-Term Benefits of Rapid Antiretroviral Therapy Initiation in Reducing Medical and Overall Health Care Costs Among Medicaid-Covered Patients with Human Immunodeficiency Virus

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of managed care & specialty pharmacy.

Rapid Initiation of Antiretroviral Therapy Following Diagnosis of Human Immunodeficiency Virus Among Patients with Commercial Insurance Coverage

P. Lefebvre, C. Benson, N. Tandon, 2019, Journal of managed care & specialty pharmacy.

End-Of-Life Medical Spending In Last Twelve Months Of Life Is Lower Than Previously Reported.

Nicolas R. Ziebarth, J. Skinner, M. Karlsson, 2017, Health affairs.